The technique of CSEA with low dose intrathecal hyperbaric bupivacaine and EVE provided rapid onset with profound surgical anaesthesia due to spinal and ability to prolong the blockade by epidural. Administration of low dose spinal with opioid and EVE not only provided adequate level of block but also provided stable haemodynamics in the peri-operative period.
Various authors [3, 4] have utilised the technique of EVE to achieve the desired effect, without significant haemodynamic effect and faster recovery of motor function. A study by Blumgart et al. [5] suggested a higher level of analgesia with EVE compared with spinal alone. This is secondary to the volume effect in epidural space which compresses the subarachnoid space and increase the intrathecal spread of the drug. Goy [6] demonstrated that the mean effective dose of intrathecal hyperbaric bupivacaine in CSE was 20% less than that in single shot spinal. Our result was similar to reports of use of the technique in pregnant females with peripartum cardiomyopathy.
[7] CSE with EVE technique has been used for gynaecological and orthopaedic surgery, but this is probably the first report of its use in renal transplantation in uremic cardiomyopathy. Myocardial infarction during pregnancy: A rare occurrence
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Sir, Pregnancy-associated acute myocardial infarction (AMI) is rare, but is associated with high morbidity and mortality. The estimated incidence of AMI during pregnancy is 3-10 cases/100,000 deliveries with a maternal mortality rate of 21% and fetal mortality rate of 13%. [1] Pregnancy-associated changes in the cardiovascular system and coagulation system increases the risk of AMI by approximately 3 to 4-fold. [1] We describe a case of AMI and its management during caesarean delivery in our institute.
A 30-year-old female, gravida 5, para 4, at 36 weeks of gestation got admitted with the complaints of bleeding per vagina and diffuse abdominal pain. Patient was in distress, but alert and oriented. Her pulse was 140/min and blood pressure (BP) was 74/46 mm Hg. After securing two peripheral lines, initial intravenous fluids resuscitation was carried out by administrating 1500 ml crystalloid (lactated ringer solution) and 500 ml colloid (hydroxyethyl starch 130/0.4). As the BP was very low dopamine infusion at 12 mcg/kg/min was started simultaneously. Over a period of time as haemodynamics improved and patient started responding to fluid therapy; dopamine infusion was titrated according to BP. On auscultation of chest normal vesicular breath sounds were heard. The cardiac examination revealed no obvious murmurs, gallops or pericardial rub. The electrocardiogram (ECG) demonstrated normal sinus rhythm with ST segment T wave changes in all leads, which was attributed to tachycardia, hypotension and anaemia. Laboratory results were as follows: Haemoglobin -5.5 g/dl, haematocrit -17.6%, total leukocyte count -14,500/ul, platelet count -.2.44 lac/ul, Random Blood Sugar (RBS) -79 mg/dl, blood urea nitrogen -23 mg/dl, S.creatinine -0.79 mg/dl, S.bilirubin -0.93 mg/dl, serum glutamic oxaloacetic transaminase/serum glutamic pyruvic transaminase -36/39 IU/L and S.alkaline phosphatase -369 IU/L. Ultrasonography revealed single intrauterine live foetus of gestational age 34.5 weeks with placenta previa grade 3. Patient received two units of packed red blood cells. Her BP picked up to 106/54 mm Hg on dopamine infusion (7 mcg/kg/min) and was posted for emergency caesarean section.
General anaesthesia was planned due to haemodynamic instability of the patient. Rapid sequence induction was performed using propofol 1 mg/kg and ketamine 1 mg/kg and concomitant preoxygenation. Endotracheal intubation was done following injection of succinylcholine 1.5 mg/kg. Patient was maintained on isoflurane 0.7% with O 2 /N 2 O (40/60) and atracurium 0.5 mg/kg. Just after delivery of baby, patient developed pulseless ventricular tachycardia. Cardiopulmonary resuscitation was started immediately. Meanwhile, defibrillator was prepared and a shock of 150 joule (biphasic waveform) was delivered. Patient reverted to sinus rhythm, but ST segment elevation appeared on continuous ECG monitoring. Injection oxytocin 10 units was added to 1 L of ringer lactate and given at a rate of 10 ml/min. Patient remained stable during the rest of surgery and was shifted to intensive care unit for elective ventilation and further management.
A 12 lead ECG in the immediate post-operative period showed normal sinus rhythm with ST segment elevation and T wave inversion in lead I, aVL and V 1 to V 4 . Laboratory results were as follows: Troponin I positive; creatinine kinase-MB fraction -39 U/L; triglycerides -310 mg/dL; total cholesterol -250 mg/dL; high-density-lipoprotein -38 mg/dL and low-density-lipoprotein -163 mg/dL. Cardiologist consultation and bedside echocardiography demonstrated left ventricular wall motion abnormalities at the apex and anterior wall; and ejection fraction of 35 to 40% and mild mitral regurgitation. Patient was treated with aspirin, clopidogrel, unfractionated heparin, metoprolol and morphine. In the next 24 h patient was weaned off from the ventilator and vasopressor support and was shifted to cardiac catheterization laboratory, where angiography revealed 80% block of left anterior descending artery, but no active intervention was done at that time. Patient was transferred to the cardiac intensive care unit (CICU) and started on a regimen of carvedilol, 12.5 mg; aspirin, 150 mg; clopidogrel, 75 mg; atorvastatin, 20 mg and ivabradine, 7.5 mg. Patient remained stable in CICU and on day 3 she was transferred back to the ward and was discharged on the 7 th day with the advice of cardiology follow-up.
The most common underlying mechanisms implicated in AMI during pregnancy are atherosclerotic coronary artery disease (CAD), coronary thrombosis with hypercoagulability and coronary artery dissection.
Complications of pregnancy that are significantly associated with AMI are severe anaemia, preeclampsia, postpartum haemorrhage, postpartum infection, shock, ergometrine, prostaglandin E1, fluid and electrolyte imbalances. [2] [3] [4] [5] All causes of tachycardia, hypertension, hypotension, anaemia and pain should be treated aggressively. The interventions include vasopressors to maintain BP, β-blockers to slow heart rate, managing blood volume, post-operative pain and respiratory function. Emergent coronary intervention, anticoagulants or glycoprotein IIb/IIIa antagonists are rarely indicated in the immediate post-operative course and are hazardous because of the risk of bleeding, unless ST elevation or intractable cardiogenic shock ensues. [6] With this case report, we highlight the possibility of presence of unknown CAD and occurrence of perioperative AMI, apart from tachycardia and anaemia in pregnant patients having ST-T changes in ECG. Tachycardia, hypotension, hypertension, anaemia, hypoxemia and systolic and diastolic myocardial dysfunction are common causes of prolonged ST-depression and myocardial infarction in patients with stable CAD undergoing major noncardiac surgery. Careful perioperative monitoring for ischemia, a low threshold for treating and preventing tachycardia while avoiding hypotension, decreased cardiac output and/or cardiac decompensation help prevent perioperative myocardial infarction (PMI). Coronary intervention is rarely indicated as the first line of treatment and antithrombotic therapy may exacerbate bleeding. Future studies are needed to determine, which patients with PMI require intensified post-operative surveillance, Dexmedetomidine in the management of severe tetanus
Although tetanus is a rare disease in the developed countries now, it remains a significant cause of death world-wide and is associated with a high rate of mortality. Components of severe tetanus management are supportive care with sedation, airway protection and controlled ventilation. [1] Dexmedetomidine is a high selective α-2-receptor agonist. It has combined analgesic and anti-sympathetic effect without respiratory system depression. There have been several studies describing its successful use in mechanically ventilated patients for short-(24 h) and long-term (up to 7 days) use in the intensive care unit (ICU). [2] Dexmedetomidine has been also used in the treatment of tetanus in six patients for 7 days. [3] We present a case of generalised tetanus complicated by uncontrolled sympathetic over activity (SOA) managed with dexmedetomidine infusion.
A 53-year-old male patient presented with complaints of dyspnoea, upper lip twitching, difficulty in swallowing and a local abscess around his right foot. He had a medical history of penetrating wound in his right foot 11 days before. Antibiotics and human tetanus immunoglobulin were administered and the wound was surgically debrided. Because of respiratory failure with SOA, he was intubated and mechanically ventilated. SOA persisted despite midazolam and magnesium sulphate infusion. Dexmedetomidine infusion was started on day 5 and SOA could be controlled successfully. On day 10, severe bronchopneumonia developed and the patient died on day 12.
The management of tetanus requires the prevention of tetanospasmin absorption, treatment of symptoms, stabilisation of autonomic instability, antibiotic therapy and control of the airway with assisted ventilation if indicated. Basal SOA is characterised by resting tachycardia and depression of bowel motility and bladder function, while severe SOA presents with fluctuating tachycardia, labile hypertension and sweating with and without stimulation. [4] Different methods to control SOA have been provided, including magnesium sulphate infusions, dantrolene infusions, intrathecal administration of baclofen, benzodiazepine, clonidine and dexmedetomidine. [5] Girgin et al. [3] reported use of dexmedetomidine in the management of tetanus for 7 days in six patients without any side-effects. According to the same author, its administration did not fully control the muscle spasm, but decreased their frequency and severity and reduced the use of sedative drugs to control muscle spasms and cardiovascular instability. In this case, we started dexmedetomidine infusion on the 5 th day in the ICU, because midazolam and magnesium sulphate infusions did not efficiently control SOA. We observed that tachycardia (heart rate >110 beats/ min) and hypertension (mean arterial blood pressure >100 mmHg) decreased to acceptable normal levels and need for sedative drugs was reduced after starting dexmedetomidine infusion. However, we were not able to fully avoid their use. We used dexmedetomidine for 4 days. Although hypotension and bradycardia are the
